McKesson Specialty Health – Pharmaceutical and Biotech Solutions
McKesson Specialty Health offers bio-pharmaceutical manufacturers an unsurpassed suite of services to accelerate the approval and successful commercialization of specialty pharmaceuticals across the product life cycle.
Our enhanced offerings, combined with a consultative, solution-focused team, enable us to provide personalized service to our manufacturer partners.
Through our Market Intelligence Solutions, we provide deep and broad insights so you can better understand the most current trends in the market place, design effective go-to-market strategies and take timely actions targeted to specific practices. The quality of our solutions is a function of several key factors including the depth of information contained in our databases, the breadth of informational categories we can access and the number of our technology users.
In addition to our informatics offerings, we offer extensive support in the field of Health-Economic and Outcomes Research. Our team of experts can help you design and execute prospective or retrospective clinical and economic studies and develop value messaging for your products. We can also provide insights into unmet medical needs.
Supply Chain Services
Licensed in 50 States, we have 177 years of experience in providing innovative and complete distribution solutions for specialty drugs. Our distribution network includes over 300,000 sq. ft of state-of-the-art facilities in three states that are VAWD-certified and execute with same day fill capabilities and over 99.99% order accuracy. Our industry-leading logistics and sophisticated cold-chain handling expertise positions us to provide you with customized solutions, including managed, exclusive and 3PL programs to ensure timely product access and complete supply chain visibility, as well as risk management programs. We also offer oral therapies dispensing through our national specialty pharmacy licensed in 50 states with an average fill time of 48 hours or less.
Patient Access to Therapy
We offer comprehensive support that help manufacturers navigate the complexities of reimbursement and enable affordable, safe access to therapy. Our solutions include strategic consulting, reimbursement services, patient assistance programs (PAPs) and inside sales services. We also manage some of the industry's most rigorous REMS programs - helping many manufacturers effectively balance the FDA mandates while meeting product commercialization goals. Our REMS services include strategic design, FDA submission, program administration, controlled distribution and surveys and assessment.
We offer targeted, tailored and efficient engagement vehicles to reach providers in formats that best suit their needs. Our solutions include peer-to-peer live educational programs led by key opinion leaders, webcast presentations on a topic of your choice (on-label) and facilitated by a seasoned moderator, highly targeted email marketing programs, marketing material fulfillment services, as well as expert events, sponsored posts and microsites or content pages on The Oncology Portal.
Through our targeted patient engagement solutions, you can educate patients on the benefits and risks of your product, but you can also provide valuable and timely information on important topics such as the appropriate length of therapy, side-effect management and the importance of treatment adherence.
For patients taking an oral oncolytic, we offer communication solutions that can be broad or targeted to patients receiving your therapy for a specific indication. In addition to targeted mail and email campaigns, we offer outbound calls by trained nurses to patients receiving your therapy through our Specialty Pharmacy.
Clinical Trial Support
McKesson Specialty Health's Clinical Data Generation Services deliver comprehensive support for a high-quality, rapid execution of your clinical trials. For more than a decade, we have been working closely with our affiliated sites, physician leadership and sponsors to develop optimal study protocols to ensure more accurate accrual targets while maintaining a high level of protocol compliance and quality of data.
US Oncology Research is one of the largest community-based oncology research networks in the United States with ~1,000 experienced investigators, as well as a central team actively supporting the sites. Our network of researchers conduct Phase I-IV trials across a large number of indications, including rare tumor types. To date, US Oncology Research and its research network have participated in the approval of nearly 1/3rd of all FDA approved agents and enrolled more than 60,000 patients.